Abstract
3557Background: TAS-102 is comprised of an antineoplastic thymidine-based nucleoside analog, trifluridine (FTD), and a thymidine phosphorylase inhibitor, tipiracil hydrochloride. Primary results of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have